RARE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RARE is expected to report earnings to fall 3.57% to -135 cents per share on February 13

Ultragenyx Pharmaceutical RARE Stock Earnings Reports

Q4'24

Est.

$-1.35

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.14

Q1'24

Missed

by $0.28

Q4'23

Beat

by $0.18

The last earnings report on November 05 showed earnings per share of -139 cents, beating the estimate of -148 cents. With 458.29K shares outstanding, the current market capitalization sits at 4.15B.

View a ticker or compare two or three

Compare

RARE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RARE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RARE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Leveroni Court

Phone

+1 415 483-8800

Employees

1276

Web

https://www.ultragenyx.com